Summary
Our speakers will be discussing how they used a Design Thinking Methodology approach for insight and prototype generation. People with both Type 1 and Type 2 diabetes were invited to co-create digital/technology solutions to support them in their daily diabetes management as a means to enhance patient engagement as part of a virtual clinical trial. The insights and recommendations gained from this established patient advisory panel can be further leveraged across other therapeutic areas that will ultimately incorporate the use of digital clinical applications. This engagement produced several ideal prototypes that would:
You may also be interested in:

Recruiting Solid Tumor Patients in a Complex ADME Trial
PRA's PPS facility in Budapest (PPS-Hungary) was contracted to run an open-label, non-randomized, Phase I study to characterize the mass balance and…

CSF Sampling
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK…

Vaccine Solutions
PRA’s Vaccine Solutions group understands the unique challenges and characteristics of vaccine development. Right from the start, our experts will…